Literature DB >> 291065

Specific changes in the surface glycoprotein pattern of human promyelocytic leukemic cell line HL-60 during morphologic and functional differentiation.

C G Gahmberg, K Nilsson, L C Andersson.   

Abstract

The human promyelocytic leukemia cell line HL-60 can be induced to undergo morphological and functional differentiation in vitro by various low molecular weight compounds. The cellular morphology changes from blastoid appearance to that of granulocytes and the cells acquire the ability to phagocytize. We here report that the surface glycoproteins specifically change during this differentiation, as shown by the neuraminidase/galactose oxidase/NaB3H4 surface-labeling technique followed by polyacrylamide slab gel electrophoresis. The most prominent change is the loss of the major glycoprotein band typical for the blast cells which has an apparent molecular weight of 160,000 and the appearance of a major surface glycoprotein band with an apparent molecular weight of 130,000. Expression of the 130,000 molecular weight band correlates with the appearance of phagocytic and chemotactic activities of the cells. It has the same molecular weight as the major surface glycoprotein of freshly isolated human blood granulocytes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 291065      PMCID: PMC383983          DOI: 10.1073/pnas.76.8.4087

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Surface glycoprotein patterns of normal and malignant human lymphoid cells. II. B cells, B blasts and Epstein-Barr virus (EBV)-positive and -negative B lymphoid cell lines.

Authors:  K Nilsson; L C Andersson; C G Gahmberg; H Wigzell
Journal:  Int J Cancer       Date:  1977-11-15       Impact factor: 7.396

2.  Surface glycoproteins of human white blood cells. Analysis by surface labeling.

Authors:  L C Andersson; C G Gahmberg
Journal:  Blood       Date:  1978-07       Impact factor: 22.113

3.  Surface glycoprotein patterns of normal and malignant human lymphoid cells. I. T cells T blasts and leukemic T cell lines.

Authors:  L C Andersson; C G Gahmberg; K Nilsson; H Wigzell
Journal:  Int J Cancer       Date:  1977-11-15       Impact factor: 7.396

4.  Activated human T lymphocytes display new surface glycoproteins.

Authors:  L C Andersson; C G Gahmberg; A K Kimura; H Wigzell
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

5.  Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia.

Authors:  L Sachs
Journal:  Nature       Date:  1978-08-10       Impact factor: 49.962

6.  Genetic dissection of the control of normal differentiation in myeloid leukemic cells.

Authors:  J Lotem; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  Differential desensitization of functional adrenergic receptors in normal and malignant myeloid cells: relationship to receptor-mediated hormone cytotoxicity.

Authors:  R Simantov; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

8.  Identification and characterization of normal and malignant human blood leukocytes by surface glycoprotein patterns.

Authors:  C G Gahmberg; L C Andersson
Journal:  Ann N Y Acad Sci       Date:  1978-06-20       Impact factor: 5.691

9.  Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.

Authors:  S J Collins; F W Ruscetti; R E Gallagher; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

10.  Selective radioactive labeling of cell surface sialoglycoproteins by periodate-tritiated borohydride.

Authors:  C G Gahmberg; L C Andersson
Journal:  J Biol Chem       Date:  1977-08-25       Impact factor: 5.157

View more
  13 in total

Review 1.  Carbohydrates as antigenic determinants of glycoproteins.

Authors:  T Feizi; R A Childs
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

2.  Gamma interferon induces monocytoid differentiation in the HL-60 cell line.

Authors:  E D Ball; P M Guyre; L Shen; J M Glynn; C R Maliszewski; P E Baker; M W Fanger
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

3.  Calcium ionophore and chemotactic peptide stimulation of peptidoleukotriene synthesis in DMSO-differentiated HL60 cells.

Authors:  J C Anthes; R W Bryant; M W Musch; K Ng; M I Siegel
Journal:  Inflammation       Date:  1986-06       Impact factor: 4.092

4.  Gene expression in HL60 granulocytoids and human polymorphonuclear leukocytes exposed to Candida albicans.

Authors:  Alaka Mullick; Miria Elias; Penelope Harakidas; Anne Marcil; Malcolm Whiteway; Bing Ge; Thomas J Hudson; Antoine W Caron; Lucie Bourget; Serge Picard; Orce Jovcevski; Bernard Massie; David Y Thomas
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 5.  Chemical carcinogenesis -- the price for DNA - repair?

Authors:  U Wintersberger
Journal:  Naturwissenschaften       Date:  1982-03

6.  Plasma membrane proteins from human normal and chronic myeloid leukemic granulocytes: identification and partial characterization of the concanavalin A-binding and detergent resistant proteins.

Authors:  S M Zingde; S H Advani; B P Gothoskar
Journal:  Blut       Date:  1987-08

7.  Urinary glycoproteins in acute leukemias: a 41 000 dalton glycoprotein follows the kinetic of cytoreduction.

Authors:  P A Maubach; B Emmerich; A Willer; A Ogilvie; J Rastetter
Journal:  Blut       Date:  1984-04

8.  Biosynthesis of the human C3b/C4b receptor during differentiation of the HL-60 cell line. Identification and characterization of a precursor molecule.

Authors:  J P Atkinson; E A Jones
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

9.  Factors affecting the CEA secretion of human adenocarcinoma cell lines into the spent medium.

Authors:  N Yamaguchi; K Kawai
Journal:  Gastroenterol Jpn       Date:  1983-10

10.  Expression of myeloid differentiation antigens on normal and malignant myeloid cells.

Authors:  J D Griffin; J Ritz; L M Nadler; S F Schlossman
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.